
Alegeți eticheta dumneavoastră
afișată direct pe flaconACE-031
Muscle Building
- Livrare din Germania
Comandă
- DHL cu urmărire
- Ambalare discretă
Pe scurt
ACE-031 în cifre
Valorile principale din lexiconul nostru.
Articolul complet din lexicon- Class
- ActRIIB-Fcmyostatin/activin trap
- Half-life
- longfusion protein
- Use
- Subcutaneousno established protocol
- Sizes
- 1 mg1 size in the shop
What studies show
All 2 sources in the lexicon- Attie et al., Muscle & Nerve, 2013
ACE-031 in boys with Duchenne muscular dystrophy (study stopped early) (opens in a new tab)
Campbell et al., Muscle & Nerve, 2017
Pentru ACE-031 nu există încă o analiză de laborator. Votați pentru elTestați-l singur, noi plătim jumătateToate analizele de laborator
Informații
Totul despre ACE-031
Informații detaliate în curând.
Util de adăugat
De ce aveți nevoie în plus
Apa bacteriostatică se adaugă automat în coș. Seringi și tampoane cu un singur clic.
Seringi de insulină
10 buc. · 5.50 €
Tampoane cu alcool
50 buc. · 10 €
Câtă apă?
Unități pe seringă pentru mărimea flaconului dumneavoastră.
Deschideți calculatorul →What is ACE-031?
A large fusion protein: the outer part of the activin receptor IIB, linked to a piece of an antibody (IgG1 Fc). It binds myostatin and related messengers in the blood before they reach the receptor on muscle. The compound name is ramatercept.
What did the first human study show?
48 healthy postmenopausal women received a single dose at ascending levels or placebo. In the group with the highest study dose lean mass rose by 3.3 percent and thigh muscle volume by 5.1 percent after 29 days. The half-life was 10 to 15 days.
Why was development stopped?
In the trial in boys with Duchenne muscular dystrophy nosebleeds and telangiectasias occurred, meaning widened small blood vessels. The trial was stopped after the second dosing regimen because of potential safety concerns. The activin receptor IIB acts not only on muscle but also on vessels.
Was there a benefit in Duchenne?
Only trends. The 6-minute walk distance tended to be maintained in the ACE-031 groups while it declined on placebo. There were also trends towards more lean mass and bone density and less fat mass. None of this was statistically significant.
Is ACE-031 approved?
No. ChEMBL lists ramatercept with phase 2 as the highest phase. ClinicalTrials.gov lists four trials from 2008 to 2011, both phase 2 trials were terminated early (as of 26 October 2026).
What do animal studies show?
In marmosets lean mass increased over 14 weeks on ACE-031, muscle fibres became thicker and muscle force rose. This did not happen in the control group. The authors see this as a pointer for muscle diseases in humans.
Produse asemănătoare
Produse similare
IGF-1 LR3
Peptide · Creștere și mușchi Creștere și mușchi
2 mărimi
= de la 11.6 €/flacon
MGF
Peptide · Creștere și mușchi Creștere și mușchi
1 mărime
= 13.2 €/flacon
PEG-MGF
Peptide · Creștere și mușchi Creștere și mușchi
1 mărime
= 22 €/flacon
FST-344 (Follistatin)
Peptide · Creștere și mușchi Creștere și mușchi
1 mărime
= 53.2 €/flacon
ACE-031